Last updated 4 days ago

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

380 patients around the world
Available in Spain, Brazil, United States
Regeneron Pharmaceuticals
4Research sites
380Patients around the world
This study is for people with
Multiple myeloma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital Sao Rafael
Recruiting
Av. São Rafael, 2152 - São Marcos, Salvador - BA, 41253-190
Hospital Tacchini
Recruiting
R. Dr. José Mário Mônaco, 358 - Centro, Bento Gonçalves - RS, 95700-000, Brazil
Hospital Mãe de Deus - Porto Alegre
Recruiting
R. José de Alencar, 286 - Menino Deus, Porto Alegre - RS, 90880-481, Brazil
Unidade de Tratamento Oncológico - ANIMI
Recruiting
R. Mal. Deodoro, 678 - Centro, Lages - SC, 88501-001
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy